Clinical Trial Update: Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a basal insulin strategy for post-transplant hyperglycemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia

Drugs mentioned

• basal insulin (unspecified) (basal insulin)

Snippet

Sponsor: Marcus Saemann | Conditions: Hyperglycemia | Phase 2 | Status: COMPLETED